311 related articles for article (PubMed ID: 21293933)
1. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
2. Macroscopic Serosal Classification as a Prognostic Index in Radically Resected Stage pT3-pT4b Gastric Cancer.
Wang HH; Huang JY; Wang ZN; Sun Z; Li K; Xu HM
Ann Surg Oncol; 2016 Jan; 23(1):149-55. PubMed ID: 26040607
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between serosal invasion types and lymph node metastasis after total gastrectomy in gastric cancer and its significance in selection of rational dissection].
Zhu HT; Zhao YL; Wu YF
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):474-7. PubMed ID: 19950563
[TBL] [Abstract][Full Text] [Related]
4. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
6. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal recurrence in serosa-negative gastric adenocarcinoma after curative surgery.
Wu CC; Chen JH; Huang KH; Fang WL; Wu CW; Lo SS; Hsieh MC; Shen KH; Li AF
Hepatogastroenterology; 2011; 58(109):1119-22. PubMed ID: 21937361
[TBL] [Abstract][Full Text] [Related]
8. Is bursectomy necessary for patients with gastric cancer invading the serosa?
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
10. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
11. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
12. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
[TBL] [Abstract][Full Text] [Related]
13. Utility of serosal stamp cytology as an indicator for high-risk peritoneal metastasis in colorectal cancer surgery.
Ojima H; Sasaki S; Fujisawa T; Ishibashi Y; Masuda N; Asao T; Kuwano H
Hepatogastroenterology; 2003; 50(49):87-90. PubMed ID: 12629998
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.
Sun Z; Wang ZN; Xu YY; Zhu GL; Huang BJ; Xu Y; Liu FN; Zhu Z; Xu HM
Surgery; 2012 Jun; 151(6):871-81. PubMed ID: 22386276
[TBL] [Abstract][Full Text] [Related]
16. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study.
Fujiwara Y; Okada K; Hanada H; Tamura S; Kimura Y; Fujita J; Imamura H; Kishi K; Yano M; Miki H; Okada K; Takayama O; Aoki T; Mori M; Doki Y
Surgery; 2014 Mar; 155(3):417-23. PubMed ID: 24439740
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between free cancer cells in the abdominal cavity, serosal type and pathologic characteristics of gastric cancer].
Liu QH
Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):430-3. PubMed ID: 3250827
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcome of serosa-negative advanced gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Anticancer Res; 2004; 24(5B):3169-75. PubMed ID: 15510607
[TBL] [Abstract][Full Text] [Related]
19. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
Saito H; Kihara K; Kuroda H; Matsunaga T; Tatebe S; Ikeguchi M
J Surg Oncol; 2011 Oct; 104(5):534-7. PubMed ID: 21618248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
